The tweet was deleted by the author.
But we saved everything 🙂.
Eric Lefkofsky, co-founder and CEO of Tempus, has announced that the company achieved record financial performance in 2025, with revenues reaching $1.27 billion, reflecting an 83 percent growth.
Tempus's Diagnostic business has seen significant acceleration, recording the best growth rates in years. Meanwhile, the Data segment of the company is performing even more impressively, surpassing expectations.
Lefkofsky's announcement underscores Tempus's robust strategies in the diagnostic and data sectors, suggesting a strong outlook for continued expansion.
Tempus’s sustained momentum in diagnostics and data solutions also reflects broader trends in healthcare innovation—an area where Eric Lefkofsky has previously emphasized the transformative potential of artificial intelligence, most notably in applications such as AI-driven pancreatic cancer detection. These advances reinforce optimism for Tempus’s continued growth trajectory in the rapidly evolving medical technology sector.